Guanosine 5'-[fly-imido]triphosphate (p[NH]ppG)-stimulated phospholipase C (PLC) activity in bovine brain coated vesicles is inhibited by glutamate agonists. In the present study we show that quisqualic acid (QA), (±)-trans-1-aminocyclopentane-1,3-dicarboxylate (trans-ACPD), glutamic acid and ibotenic acid inhibited p[NH]ppG-stimulated PLC by 44, 41, 36 and 25% respectively. Carbachol also produced an inhibition of p[NH]ppG-stimulated PLC by 45 %. The inhibition caused by trans-ACPD and QA was dose-dependent. DL-2-Amino-3-phosphonopropionic acid and (RS)-a-methyl-4-carboxyphenylglycine, specific antagonists of metabotropic glutamate receptors (mGluRs), abolished these inhibitory effects. trans-ACPD in-
INTRODUCTION
Glutamate acts as a neurotransmitter in the central nervous system by interacting with specific membrane receptors. The functional diversity of glutamate results from the presence of multiple glutamate receptors which can be categorized into two main groups termed ionotropic and metabotropic receptors 111.
At least seven metabotropic glutamate receptors (mGluRs) have been described by molecular cloning [2] [3] [4] [5] [6] . These receptors are coupled to G-proteins and evoke a variety of functions through different signal transduction systems and effectors, including the phosphatidylinositol/Ca2+ cascade and inhibition of adenylyl cyclase.
Receptor-mediated activation of phospholipase C (PLC) involves the participation of G-proteins. By analogy with the adenylyl cyclase system, it has been suggested that PLC may be regulated via distinct G-proteins, which could activate or inhibit through stimulatory or inhibitory receptors respectively [7] . In fact, a dual regulation of PLC activity by guanine nucleotides has been shown in rat cerebral cortical membranes [8] and bovine brain coated vesicles [9] . Members of the Gq family have been reported to mediate pertussis toxin-insensitive stimulation of PLC [10] . Inhibition of stimulated PLC activity by glutamate analogues [11, 12] as well as by other agonists, such as adenosine [13] , carbachol [14] or opioid agonists [15] , have been reported. Depending on the system studied, these inhibitory effects on stimulated-PLC activity have been explained through an indirect mechanism, probably mediated by calcium [16] or by direct coupling of their receptors with the PLC effector system [14, 15] . Recently, Litosch et al. [17] have demonstrated G-protein-mediated inhibition of PLC fl1 in bovine brain solubilized membrane hibition of p[NH]ppG-stimulated PLC was also observed in the presence of ionotropic glutamate receptor antagonists. When carbachol and QA or trans-ACPD were combined, additive inhibitory effects were observed. Preincubation of bovine brain coated vesicles with pertussis toxin abolished the inhibitory effects of mGluR analogues and carbachol on p[NH]ppGstimulated PLC activity. The presence of G,a and pertussis toxin substrates, Gia and Goa subunits as well as PLC f1 in bovine brain coated vesicles has been confirmed by immunoblot. These results support the coupling of mGluRs to a PLC in an inhibitory manner through a pertussis toxin-sensitive G-protein in bovine brain coated vesicles.
preparation. However, identification and/or direct correlation between receptor-mediated inhibition of PLC and any characterized G-protein remains to be elucidated.
The presence of mGluRs [18, 19] and PLC activity [9] in bovine brain coated vesicles has been described, suggesting that these organelles may play a role in the translocation and/or regulation ofthe G-protein-coupled receptors, as other authors have pointed out [20, 21] . In this report we present evidence for the coupling of mGluRs, found in bovine brain coated vesicles, to a PLC activity in an inhibitory manner through a pertussis toxin-sensitive Gprotein. Preparation of bovine brain membranes and coated vesicles Bovine brain membranes were obtained as described by Recasens et al., [22] using 10 mM potassium phosphate buffer, pH 7.5. Cerebral cortex (2 g) were minced and homogenized (Dounce tissue grinder) in a buffer containing protease inhibitors [100 ,uM phenylmethanesulphonyl fluoride (PMSF), 7.3 mI.U./ml bacitracine]. P2 fraction was obtained after centrifugation at 17 000 g for 20 min. Membranes were lysed for 30 min at 4°C and washed twice. Bovine brain coated vesicles were obtained by Sephacryl S-1000 gel filtration as described by Bar-Zvi and Branton [23] and modified by Gonzailez-Calero et al. [24] . Briefly, 300 g of cortex brain tissue was homogenized in a Waring blender in a ratio of 1: 2 (w/v) tissue: isolation buffer (10 mM MES/NaOH, 100 mM KCI, 1 mM EGTA, 0.5 mM MgCl2, 0.1 mM dithiothreitol, 0.02% NaN3, 7.3 ml. U./ml bacitracine and 0.1 mM PMSF, pH 6.5, at room temperature). Crude coated vesicles were obtained by centrifugation (40 min at 42000 g) in a Ficollsucrose solution (12.5 % w/v Ficoll 400/12.5 % sucrose) in isolation buffer, followed by centrifugation for 1 h at 100000 g. Crude coated vesicles (10 mg in 3 ml) were loaded onto a Sephacryl S1000 column (1.6 x 70 cm). Purified coated vesicles were finally obtained by centrifugation of Peak II as described previously [24] . This preparation yielded 6-8 mg of coated vesicles.
MATERIALS AND METHODS
Preparation of stripped vesicles Stripped vesicles were prepared as described by GeorgievaHanson et al. [25] . Coated vesicles (2-5 mg) from Sephacryl S1000 column purification were incubated in 0.5 M Tris/HCl buffer, pH 7.8 (25 ml), for 3 h at 4°C under gentle shaking conditions. The stripped vesicles were then sedimented for 1 h at 100000 g and resuspended in a suitable buffer. 
Pertussis toxin ADP-ribosylation
Pertussis toxin ADP-ribosylation was carried out as described earlier [9] . Coated vesicles were incubated with preactivated pertussis toxin (1 jug pertussis toxin/100 jug protein) or vehicle for 30 min at 30°C in a final volume of 1 ml in 100 mM potassium phosphate buffer, pH 7.4, containing 1 mM EDTA, 2 mM MgCl2, 2 mM NADI, 1 mM ATP, 100 FaM GTP and protease inhibitors (50 ,ug/ml leupeptin and 50 ,ug/ml aprotinin).
After incubation, samples were centrifuged at 100000g for 30 min and coated vesicles were washed and resuspended in isolation buffer before PLC assays or used in a second toxincatalysed ADP-ribosylation in the presence of [32P]NAD+, followed by electrophoresis as described previously [28] .
Immunoblot analysis Bovine brain coated vesicles and stripped vesicles (25-100 ug of protein) were subjected to electrophoresis on 10 % (7 %, when anti-PLC was used) polyacrylamide gels in the presence of SDS and were electrophoretically transferred to nitrocellulose, blocked for 1 h with 5 % (w/v) non-fat skimmed milk in PBS, pH 7.2, as described earlier [29] . The blots were probed with the following commercial antisera RM/1 (anti-G,a), AS/7 (antiGial,2), GC/2 (anti-G0a) and the monoclonal anti-PLC ,f1. After washing with 0.3 % Tween 20 in PBS, second goat anti-rabbit antiserum coupled to horseradish peroxidase was added (1:1000 in PBS) in the case of G-protein subunits. In the case of PLC antibody, a goat anti-mouse antiserum coupled to horseradish peroxidase was used. After washing, specific bands corresponding to Ga-protein subunits were detected using 4-chloro-1-naphthol as substrate. The band corresponding to PLC /l1 was visualized by use of a chemiluminiscent reagent, using the ECL Kit from Amersham.
SDS/PAGE Samples containing 25-50 ,ug of protein were analysed on 10 or 7 % PLC fi1-polyacrylamide gels containing 0.1 % SDS as described earlier [30] .
Protein determination
Protein concentration was determined by the method of Lowry et al. [31] , using BSA as standard.
RESULTS
Effect of excitatory amino acids on PLC activity in bovine brain coated vesicles Coated vesicles have been purified by several steps of differential centrifugation combined with Sephacryl S-1000 chromatography as described previously [24] . This method yields a coated vesicle preparation with a typical electrophoretic profile (see Figure 2a ) and minimal contamination [24] . 1.88 ± 0.14 (7) 6.44 ± 0.763 (5) 3.4+0. [9] .
To assess further the presence of PLC activity in bovine brain coated vesicles and its putative coupling to mGluRs, the assays were performed using the different glutamate agonists that have been described as mGluR analogues [5] . As shown in Table 2 , the Bovine brain coated vesicles (10) (11) (12) (13) (14) (15) ,ug) were incubated as described in the Materials and methods section and in the legend of Pertussis toxin effect on PLC activity In bovine brain coated vesicles PLC activity in coated vesicles has been shown to be regulated by guanine nucleotides in a biphasic manner: inhibiting in the nanomolar range and stimulating in the micromolar range, suggesting that the enzyme is regulated by putative inhibitory and stimulatory G-proteins, respectively [9] . Given that the inhibitory pathway has been shown to be pertussis toxin-sensitive in bovine brain coated vesiscles [9] and that pertussis toxin decreases the affinity of metabotropic glutamate binding sites for its agonist in coated vesicle preparations [19] , the effects of this toxin on the inhibitory effects ofglutamate agonist on p[NH]ppGstimulated PLC activity were studied. In agreement with the data presented in Table 2 , Figure 1 shows that both QA and trans-ACPD inhibited PLC activity in a dose-dependent manner in coated vesicles preincubated in the absence of pertussis toxin, QA being more potent than trans-ACPD, in accordance with the results shown above (Table 2 ). These inhibitory effects were abolished when coated vesicles were preincubated with pertussis toxin (Figure 1) 47 kDa, corresponding to G,a forms, were described in coated vesicles as a result of pertussis and cholera toxin catalysed ADPribosylation respectively. In an approach to assess and identify the G-proteins present in coated vesicles, immunoblotting with specific antisera was carried out. Figure 2(a) shows the electrophoretic pattern of coated vesicles, PII corresponds to coated vesicles obtained from the Sephacryl S-1000 column, which contain the clathrin heavy chain (180 kDa) as the major component as well as the light chains (33-36 kDa) and the other two major family proteins (100-1 15 kDa; 50-55 kDa) implicated in clathrin assembly to the plasma membrane, termed adaptor proteins, and PII-Clt corresponds to the proteins of stripped vesicles, showing a relatively small quantity of the 180 kDa clathrin heavy chain. Since clathrin constitutes more than 50 % of the coated vesicles protein content, we tried to eliminate most of it before the immunoblotting assay by using an alkaline buffer treatment [25] . Previous reports had shown that this gentle treatment maintains the functional integrity of coated vesicles [181. Figure 2(b) shows immunoblots of decoated vesicles probed with AS/7, RM/ 1 and GC/2, polyclonal antibodies which recognizes Gial 2' Gsa and aGoa respectively. As can be observed, a band of 40 kDa is detected with AS/7 antibody. As this antiserum recognizes two proteins, Gial and Gia2, with very close molecular mass, the resulting band could represent one of them or a combination of both. The bands detected with RM/ 1 antibody confirmed the presence of Gsa forms in coated vesicles. These data agree well with those of Ozaki et al. [34] who also described the presence of G1 and Gs subunits in coated vesicles.
On the other hand, antiserum GC/2 demonstrates the presence of Goa (39 kDa candidate to be involved in this inhibitory pathway. As can be observed in Figure 3 , PLC was detected by immunoblot in bovine brain coated vesicles. All these results suggest the presence in bovine brain coated vesicles of a PLC activity coupled to an mGluR in an inhibitory manner through a Pertussis toxin-sensitive G-protein and confirm the presence of several G-proteins and PLC /, in these intracellular organelles.
DISCUSSION
Evidence about the linkage of a single receptor subtype to multiple transduction pathways has recently been accumulated among the members of the G-protein-coupled receptors. At least seven mGluRs have been cloned, expressed in different cell lines and their coupling to transducing enzymes has been analysed [2] [3] [4] [5] [6] . So far, none of these receptors has been reported to inhibit PLC activity, whereas two products of the clones are positively coupled to the enzyme [2, 5] and the others have been shown to be coupled to the inhibitory cascade of cyclic AMP generation [4, 6] .
In the present report we found a negative regulation of PLC activity in bovine brain coated vesicles. Under our experimental conditions, QA and trans-ACPD are able to inhibit the p[NH]ppG-stimulated hydrolysis of the phosphatidyl [2-3H]-inositol 4,5-bisphosphate ([3H]PtdInsP2), in bovine brain coated vesicles (Tables 1 and 2 ). The inhibition of p[NH]ppG-stimulated PLC activity caused by trans-ACPD is still observed in the presence of MK-801 and CNQX, indicating that this effect is not mediated by ionotropic glutamate receptors, which have been proposed to act indirectly on the PLC activity [11] . On the other hand, DL-AP3 and MCPG, two different and selective antagonists of mGluR, abolished the inhibitory effects of the above mentioned glutamate metabotropic agonist (Table 3 ). The presence of mGluRs [19] and muscarinic receptors [35] and this inhibition is additive to the inhibition produced by trans-ACPD and QA (Table 2 ). These data suggest that these neurotransmitters act through different receptor pathways and that this muscarinic receptor remains coupled in an inhibitory manner in coated vesicles. The existence of a muscarinic receptor coupled to PLC activity in an inhibitory manner has been previously described in rat thyroid cells [14] . The fact that pertussis toxin interferes with both pathways could be explained (besides the possible use of the same G-protein by both receptors) by the presence of several pertussis toxin substrates in coated vesicles, as demonstrated by immunoblot. Thus, each receptor might use different pertussis toxin-sensitive G-proteins.
Data using different mGluR agonists and dose-response curves ( Table 2 and Figure 1 ) indicate that the pharmacological profile for the inhibition of PLC activity stimulated in the presence of p[NH]ppG correlates with the mGluR that we described by binding assays in bovine brain coated vesicles [18, 19] and shows a similar pharmacology to that described by Tanabe et al. [4] for the mGluR2 subtype coupled to the inhibitory cyclic AMP cascade. The range of concentrations needed to obtain inhibition by glutamate analogues in this preparation (Figure 2 ) is wider than in other reports where plasma membrane preparations are used, which could be for several reasons, such as the lack of specific analogues for the different mGluRs, the fact that the micro-environment of receptors and G-proteins play an important role in their coupling [36, 37] and the possibility that receptor-G-protein coupling for different receptors might be differently affected upon their translocation from plasma membranes into coated vesicles. In this sense, pharmacological differences between adenosine Al receptors from plasma membrane and coated vesicles have been reported [37] . Otherwise different affinity states for mGluRs in bovine brain coated vesicles have been found [19] . This inhibitory receptor might be a candidate for a new subclass of mGluRs that could represent either a different protein (i.e. with a different sequence) or one of the already known receptors coupled to a different transducing enzyme in a manner not yet described in other systems and preparations. It is now recognized that large sets of receptors are coupled to effectors by more than one G-protein and that the same neurotransmitter may act through the same effector system in a stimulatory and inhibitory manner, depending on the cell type studied or the brain region [38] .
As shown in Figure 3 , PLC 81 is present in coated vesicles.
This enzyme has been shown to be inhibited through a Gprotein-mediated mechanism in bovine brain solubilized membranes [17] . This makes PLC /81 a good candidate as the effector system that is under negative control by trans-ACPD in coated vesicles. Nevertheless, further investigations would be necessary to elucidate this point.
A major finding of the present study is that PLC activity in coated vesicles is coupled to the mGluRs through a pertussistoxin sensitive G-protein. The inhibition produced by QA and trans-ACPD was eliminated when bovine brain coated vesicles were treated with pertussis-toxin (Figure 1) . These results and the dependence of PLC activity on GTP analogues [9] support the notion of the coupling of this system through a G-protein in coated vesicles and confirm previous results where an inhibitory pathway of the PLC in bovine brain coated vesicles was shown to be mediated by a pertussis toxin-sensitive G-protein [9] . Although the presence of pertussis toxin substrates of 40 kDa have been previously described [28] , the present report shows by immunoblotting that Giac12 and Goa are present in bovine brain coated vesicles and hence are candidates to mediate the inhibitory action of glutamate and carbachol on stimulated PLC activity (Figure 2 ). On the other hand, as pertussis toxin does not affect the stimulation of PLC in coated vesicles [19] and PLC /J, has also been described as the effector for the Gq/Gll-mediated stimulation of PLC [39] , it is possible that a member of this Gprotein family also mediates stimulation in coated vesicles. Nevertheless, identification and/or direct correlation between receptor-mediated stimulation or inhibition of PLC and any known G-protein in coated vesicles remains to be elucidated.
The presence of the inhibitory signal transduction systems coupled to their receptors in bovine brain coated vesicles [24] could be explained on the basis of the tighter coupling of the inhibitory receptors to their G-proteins compared with the interaction of stimulatory receptors with their stimulatory Gproteins [40] [41] [42] . The presence of several G-protein coupled receptors in coated vesicles have been reported [22, 24, 43] . However, in contrast to the plasma membrane, only receptors that act by inhibiting the generation of second messengers have been reported to remain coupled to their effector system in these subcellular fractions [24] . This would agree with the lack of effect of trans-ACPD in plasma membranes, where its inhibitory action on PLC may be counterbalanced by the stimulatory effects of GTP analogues. In addition, it has been demonstrated that pertussis toxin-sensitive Gi can be selectively depleted from the plasma membrane [44] . The fact that the inhibitory effects of glutamate analogues and carbachol are detected only in coated vesicles agrees with the above mentioned idea of a selective enrichment of the inhibitory components in intracellular compartments. This redistribution into intracellular compartments could be a general consequence of the internalization process in the regulation of many cell surface molecules. These selective effects and the observation that the inhibitory coupling remains in intracellular compartments, as well as the physiological meaning, remains an exciting field to be elucidated.
